Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa

ClinicalTrials.gov ID: NCT00782340

Public ClinicalTrials.gov record NCT00782340. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 4:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III, Multi-Center, Study to Assess the Clinical Effect of Droxidopa in Subjects With Primary Autonomic Failure, Dopamine Beta Hydroxylase Deficiency or Non-Diabetic Neuropathy and Symptomatic NOH

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to see whether droxidopa is effective in treating symptoms of neurogenic orthostatic hypotension in patients with Primary Autonomic Failure (Pure Autonomic Failure, Multiple System Atrophy, Parkinson's Disease), Non-diabetic neuropathy, or Beta Hydroxylase deficiency.

Study identification

NCT ID
NCT00782340
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Chelsea Therapeutics
Industry
Enrollment
263 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2008 (Type not available)
Primary completion
Sep 2010 (Actual)
Completion
Sep 2010 (Actual)
Last update posted
May 16, 2014

2008 – 2010

United States locations

U.S. sites
14
U.S. states
12
U.S. cities
14
Facility City State ZIP Site status
North Alabama Neuroscience Huntsville Alabama 35801 —
Mayo Clinic-Arizona Scottsdale Arizona 85340 —
Arkansas Cardiology Little Rock Arkansas 72205 —
University of California, Irvine Irvine California 92697 —
Bradenton Neurology, Inc Bradenton Florida 34205 —
Suncoast Neuroscience Associates, Inc St. Petersburg Florida 33701 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Cncs, Ninds,Nih Bethesda Maryland 20892 —
Nerological Reserch Center at Hattiesburg Hattiesburg Mississippi 39401 —
North Shore Hospital Manshasette New York 11030 —
Pennsylvania Hospital of the University of PA Health System- Department of Neurology Philadelphia Pennsylvania 19107 —
HAN Neurological Associates Upland Pennsylvania 19013 —
Baylor College of Medicine Houston Texas 77030 —
Evergreen Hospital Medical Center; Booth Gardner Parkinson's Care Center Kirkland Washington 98034 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00782340, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 16, 2014 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00782340 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →